BI-3231
Product Specifications
UNSPSC Description
BI 3231 is a potent and selective hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13) inhibitor, with IC50s of 1 and 13 nM for hHSD17B13 and mHSD17B13, respectively. BI 3231 has the potential for the research of nonalcoholic steatohepatitis (NASH) and other liver diseases[1].
Target Antigen
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/bi-3231.html
Solubility
DMSO : 125 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C1N(CC)C(C(C)=CN1CC2=NN=C(C3=CC=C(F)C(O)=C3F)S2)=O
Molecular Weight
380.37
References & Citations
[1]Thamm S, et, al. Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. J Med Chem. 2023 Feb 2.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148814/BI-3231-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148814/BI-3231-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2894848-07-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1390407-01 0.02 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Epoxyqueuosine reductase (queG)
Ask
View Details MBS1390407-02 0.02 mg (Yeast)
Recombinant Xanthomonas campestris pv. campestris Epoxyqueuosine reductase (queG)
Ask
View Details MBS1390407-03 0.1 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Epoxyqueuosine reductase (queG)
Ask
View Details